Hepato-Renal Syndrome

Angeli P, Volpin R, Gerunda G, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29:1690-1697, 1999
PMID: 10347109
http://www3.interscience.wiley.com/cgi-bin/fulltext/106596369/PDFSTART

Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and SBP. Gastroenterology 120:726-748, 2001.
PMID 11208746.
http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WFX-45SR935-53-1&_cdi=6806&_user=128632&_orig=search&_coverDate=02%2F28%2F2001&_sk=998799996&view=c&wchp=dGLbVtb-zSkzk&md5=73b6d0fcbbd4f34ac3ab897af00eeeb7&ie=/sdarticle.pdf

Salerno F, Gerbes A, Ginés P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56:1310-1318, 2007
PMID: 17389705
http://gut.bmj.com/cgi/content/full/56/9/1310
This link brings up a button that you click for a manual download.

Sanyal AJ, Boyer T, Garcia-Tsao G, et al, Terlipressin Study Group. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134:1360-1368, 2008.
PMID: 18471513
http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WFX-4RTW3NH-3-C&_cdi=6806&_user=128632&_orig=search&_coverDate=05%2F31%2F2008&_sk=998659994&view=c&wchp=dGLbVlW-zSkzS&md5=8914e78a07a811e65bf718a8d1a010d9&ie=/sdarticle.pdf

Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403-409, 1999.
PMID: 10432325
http://content.nejm.org/cgi/reprint/341/6/403.pdf